Dostarlimab
Showing 1 - 25 of 53
Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)
Not yet recruiting
- Adenocarcinoma - GEJ
- Gastric Adenocarcinoma
- Dostarlimab
- (no location specified)
Sep 26, 2023
Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)
Not yet recruiting
- Ovarian Clear Cell Carcinoma
- Dostarlimab
- LB-100
-
Houston, TexasM D Anderson Cancer Center
Sep 26, 2023
Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)
Not yet recruiting
- Recurrent Cancer
- +2 more
- Dostarlimab
-
Lyon, FranceCentre Léon Bérard
May 12, 2023
Tumors, Rectal Trial (Dostarlimab)
Not yet recruiting
- Neoplasms, Rectal
- Dostarlimab
- (no location specified)
Feb 2, 2023
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
DOstarlimab in Recurrent or dMMR/MSI-H Endometrial Cancer
Not yet recruiting
- Endometrial Cancer
- Dostarlimab
- (no location specified)
Feb 14, 2023
Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)
Not yet recruiting
- Refractory HIV Associated Kaposi Sarcoma
- Dostarlimab in Combination Antiretroviral Therapy
- (no location specified)
Dec 2, 2022
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023
Gestational Trophoblastic Neoplasia Trial in Miami (Dostarlimab)
Not yet recruiting
- Gestational Trophoblastic Neoplasia
- Dostarlimab
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Nov 4, 2022
Head Neck Cancer Trial in Cincinnati, Columbus (Niraparib, Dostarlimab)
Active, not recruiting
- Head and Neck Cancer
- Niraparib
- Dostarlimab
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Jan 31, 2023
Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)
Not yet recruiting
- Gynecologic Cancer
- +3 more
- Cabo + Dostarlimab
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023
Brain Metastases Trial in Houston (Niraparib, Dostarlimab)
Not yet recruiting
- Brain Metastases
- Niraparib
- Dostarlimab
-
Houston, TexasM D Anderson Cancer Center
Jan 17, 2023
Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)
Not yet recruiting
- Recurrent Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 12, 2023
Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)
Not yet recruiting
- Endometrial Cancer
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2023
Head and Neck Squamous Cell Carcinoma Trial in Spain (Dostarlimab, Niraparib, cisplatin plus radiotherapy)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Dostarlimab
- +2 more
-
Badalona, Cataluña, Spain
- +4 more
Mar 13, 2023
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer Trial (Niraparib, Dostarlimab)
Not yet recruiting
- Recurrent Ovarian Cancer
- +2 more
- Niraparib
- Dostarlimab
- (no location specified)
Jul 26, 2022
Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)
Recruiting
- Rectal Neoplasms
- Rectal Neoplasm Malignant
- Niraparib
- +2 more
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Dostarlimab (TSR-042) (singly)
- Dostarlimab (TSR-042) and TSR-022 (combination)
-
Washington, District of Columbia
- +2 more
Feb 22, 2022
Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)
Recruiting
- Stage I Breast Cancer
- +7 more
- Niraparib
- Dostarlimab
-
Baltimore, Maryland
- +6 more
Nov 11, 2022
Colon Cancer, DMMR Colorectal Cancer Trial (Dostarlimab)
Not yet recruiting
- Colon Cancer
- DMMR Colorectal Cancer
- Dostarlimab
- (no location specified)
Feb 4, 2022
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Niraparib
- +2 more
-
Boston, Massachusetts
- +2 more
Oct 18, 2021
Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Niraparib
- +2 more
-
Washington, District of Columbia
- +2 more
Apr 13, 2022
Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)
Recruiting
- Endometrial Cancer
- Intensity modulated radiation therapy (IMRT)
- Dostarlimab
-
Basking Ridge, New Jersey
- +6 more
Jul 5, 2022